Wilms' Tumor (Nephroblastoma) - Pipeline Review, H2 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Wilms' Tumor (Nephroblastoma) - Pipeline Review, H2 2016" report to their offering.

Wilms' tumor or nephroblastoma is cancer of the kidneys that typically occurs in children, rarely in adults. Its common name is an eponym. Wilms' tumor is a rare kidney cancer that primarily affects children. Wilms' tumor most often occurs in just one kidney, though it can sometimes be found in both kidneys at the same time. Typical symptoms are: an abnormally large abdomen, abdominal pain, fever, nausea and vomiting, blood in the urine (in about 20% of cases) and high blood pressure in some cases.

This report provides comprehensive information on the therapeutic development for Wilms' Tumor (Nephroblastoma), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Wilms' Tumor (Nephroblastoma) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Mentioned:

  • Exelixis Inc
  • NanoSmart Pharmaceuticals Inc
  • Recombio SL
  • Selvita SA

Key Topics Covered:

  1. Introduction
  2. Wilms' Tumor (Nephroblastoma) Overview
  3. Therapeutics Development
  4. Pipeline Products for Wilms' Tumor (Nephroblastoma) - Overview
  5. Pipeline Products for Wilms' Tumor (Nephroblastoma) - Comparative Analysis
  6. Wilms' Tumor (Nephroblastoma) - Therapeutics under Development by Companies
  7. Wilms' Tumor (Nephroblastoma) - Therapeutics under Investigation by Universities/Institutes
  8. Wilms' Tumor (Nephroblastoma) - Pipeline Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Wilms' Tumor (Nephroblastoma) - Products under Development by Companies
  13. Wilms' Tumor (Nephroblastoma) - Products under Investigation by Universities/Institutes
  14. Wilms' Tumor (Nephroblastoma) - Companies Involved in Therapeutics Development

For more information about this report visit http://www.researchandmarkets.com/research/s5qkvb/wilms_tumor

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Oncology Drugs , Kidney Cancer Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Oncology Drugs , Kidney Cancer Drugs